IN186820B - - Google Patents

Info

Publication number
IN186820B
IN186820B IN921CA1996A IN186820B IN 186820 B IN186820 B IN 186820B IN 921CA1996 A IN921CA1996 A IN 921CA1996A IN 186820 B IN186820 B IN 186820B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Pilar Lupon Roses
Jaime Tomas Navarro
Salvador Puig Torres
Jordi Frigoia Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of IN186820B publication Critical patent/IN186820B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN921CA1996 1995-05-31 1996-05-21 IN186820B (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.

Publications (1)

Publication Number Publication Date
IN186820B true IN186820B (ja) 2001-11-17

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
IN921CA1996 IN186820B (ja) 1995-05-31 1996-05-21

Country Status (29)

Country Link
US (1) US5872125A (ja)
EP (1) EP0771798A1 (ja)
JP (1) JPH10503532A (ja)
CN (1) CN1076020C (ja)
AR (1) AR003952A1 (ja)
AU (1) AU699210B2 (ja)
BG (1) BG62966B1 (ja)
CA (1) CA2196425A1 (ja)
CO (1) CO4700461A1 (ja)
CZ (1) CZ24797A3 (ja)
EE (1) EE9700067A (ja)
ES (1) ES2099031B1 (ja)
GE (1) GEP20002241B (ja)
HU (1) HUP9700284A3 (ja)
IL (1) IL118494A0 (ja)
IN (1) IN186820B (ja)
IS (1) IS4420A (ja)
MA (1) MA23883A1 (ja)
MX (1) MX9700792A (ja)
NO (1) NO310073B1 (ja)
NZ (1) NZ308110A (ja)
PL (1) PL318280A1 (ja)
RU (1) RU2178789C2 (ja)
SK (1) SK12697A3 (ja)
TR (1) TR199600455A2 (ja)
UY (1) UY24241A1 (ja)
WO (1) WO1996038439A1 (ja)
YU (1) YU32396A (ja)
ZA (1) ZA964139B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
WO1996038439A1 (es) 1996-12-05
ES2099031A1 (es) 1997-05-01
EE9700067A (et) 1997-10-15
TR199600455A2 (tr) 1996-12-21
IS4420A (is) 1997-01-29
UY24241A1 (es) 1996-06-14
CN1076020C (zh) 2001-12-12
CO4700461A1 (es) 1998-12-29
HUP9700284A2 (en) 1997-11-28
BG62966B1 (bg) 2000-12-29
JPH10503532A (ja) 1998-03-31
CN1158128A (zh) 1997-08-27
BG101176A (en) 1997-08-29
SK12697A3 (en) 1997-07-09
AU5765096A (en) 1996-12-18
YU32396A (sh) 1999-07-28
CA2196425A1 (en) 1996-12-05
IL118494A0 (en) 1996-09-12
AR003952A1 (es) 1998-09-30
HUP9700284A3 (en) 1998-01-28
EP0771798A1 (en) 1997-05-07
GEP20002241B (en) 2000-09-25
CZ24797A3 (en) 1997-05-14
NO970392D0 (no) 1997-01-29
MX9700792A (es) 1997-05-31
ZA964139B (en) 1997-02-06
AU699210B2 (en) 1998-11-26
NO310073B1 (no) 2001-05-14
RU2178789C2 (ru) 2002-01-27
NZ308110A (en) 1997-08-22
MA23883A1 (fr) 1996-12-31
ES2099031B1 (es) 1997-12-01
NO970392L (no) 1997-04-01
US5872125A (en) 1999-02-16
PL318280A1 (en) 1997-06-09
HU9700284D0 (en) 1997-04-28

Similar Documents

Publication Publication Date Title
DE69638352D1 (ja)
DE69637714D1 (ja)
BRPI9612258B1 (ja)
ECSDI950232S (ja)
DK143195A (ja)
CH0741373H1 (ja)
DK0727898T3 (ja)
BR7502120U (ja)
ECSDI950231S (ja)
ECSDI950230S (ja)
ECSDI950229S (ja)
ECSDI950223S (ja)
ECSDI950233S (ja)
DK126096A (ja)
AU1627395A (ja)
BR7501503U (ja)
CN3033771S (ja)
CN3036463S (ja)
CN3031926S (ja)
CN3032390S (ja)
CN3032568S (ja)
CN3032692S (ja)
CN3033225S (ja)
CN3033635S (ja)
CN3031655S (ja)